258 related articles for article (PubMed ID: 25332687)
1. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.
He S; Tao YX
Int J Biol Sci; 2014; 10(10):1128-37. PubMed ID: 25332687
[TBL] [Abstract][Full Text] [Related]
2. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
Tao YX
Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
[TBL] [Abstract][Full Text] [Related]
4. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants.
Sharma S; Thibodeau S; Lytton J
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884
[TBL] [Abstract][Full Text] [Related]
5. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
[TBL] [Abstract][Full Text] [Related]
6. Functions of transmembrane domain 3 of human melanocortin-4 receptor.
Mo XL; Yang R; Tao YX
J Mol Endocrinol; 2012 Dec; 49(3):221-35. PubMed ID: 23014838
[TBL] [Abstract][Full Text] [Related]
7. Alanine Scanning Mutagenesis of the DRYxxI Motif and Intracellular Loop 2 of Human Melanocortin-4 Receptor.
Yang LK; Tao YX
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076233
[TBL] [Abstract][Full Text] [Related]
8. Biased signaling in naturally occurring mutations in human melanocortin-3 receptor gene.
Yang F; Huang H; Tao YX
Int J Biol Sci; 2015; 11(4):423-33. PubMed ID: 25798062
[TBL] [Abstract][Full Text] [Related]
9. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects.
Tao YX; Segaloff DL
J Clin Endocrinol Metab; 2005 Oct; 90(10):5632-8. PubMed ID: 16030156
[TBL] [Abstract][Full Text] [Related]
10. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
Yang Z; Tao YX
Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic functions of the transmembrane domain 6 of human melanocortin-4 receptor.
Huang H; Tao YX
J Mol Endocrinol; 2012 Dec; 49(3):237-48. PubMed ID: 23014839
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).
Hainer V; Aldhoon Hainerová I; Kunešová M; Taxová Braunerová R; Zamrazilová H; Bendlová B
Physiol Res; 2020 Sep; 69(Suppl 2):S245-S254. PubMed ID: 33094623
[TBL] [Abstract][Full Text] [Related]
13. Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations.
Wang ZQ; Tao YX
Biochim Biophys Acta; 2011 Sep; 1812(9):1190-9. PubMed ID: 21729752
[TBL] [Abstract][Full Text] [Related]
14. Mutations in melanocortin-4 receptor and human obesity.
Tao YX
Prog Mol Biol Transl Sci; 2009; 88():173-204. PubMed ID: 20374728
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor.
Tan K; Pogozheva ID; Yeo GS; Hadaschik D; Keogh JM; Haskell-Leuvano C; O'Rahilly S; Mosberg HI; Farooqi IS
Endocrinology; 2009 Jan; 150(1):114-25. PubMed ID: 18801902
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
18. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
[TBL] [Abstract][Full Text] [Related]
19. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.
Brouwers B; de Oliveira EM; Marti-Solano M; Monteiro FBF; Laurin SA; Keogh JM; Henning E; Bounds R; Daly CA; Houston S; Ayinampudi V; Wasiluk N; Clarke D; Plouffe B; Bouvier M; Babu MM; Farooqi IS; Mokrosiński J
Cell Rep; 2021 Mar; 34(12):108862. PubMed ID: 33761344
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
